Pfizer-Innovent $10.5B Deal & China Licensing Playbook
Examine the $10.5B Pfizer-Innovent collaboration. This analysis covers their 12-drug ADC oncology portfolio and the China cross-border licensing playbook.
Back to Articles
Articles tagged with “multispecific-antibodies”